Fourth Quarter revenue increases to $27.3 millionFourth quarter profitability grows to $2.2 million or $0.15/shareSubsidiaries to open in Japan, Australia and CanadaBOTHELL, WA, February 12, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced increased revenue, gross margin and net income for the fourth quarter ended December 31, 2003 as compared with the fourth quarter of 2002.Revenue in the fourth quarter of 2003 grew to $27.3 million, a 9 percent increase over the fourth quarter of 2002. For the full year 2003, revenue increased 16 percent to $84.8 million compared with $73.0 million in 2002.The Company reported that net income increased 158 percent to $2.2 million or $0.15 per share for the fourth quarter of 2003 compared with $0.9 million or $0.06 per share in the prior year quarter. For the full year 2003, Sonosite reported a net loss of $1.8 million or $0.12 per share versus a net loss of $7.7 million or $0.59 per share for 2002. As of December 31, 2003, cash, cash equivalents and investments totaled $61.0 million.… [Read more]
Revenues Increase 33.6 Percent Worldwide and Gross Margins Rise for the Ninth Consecutive Quarter to 62.9 PercentBOTHELL, WA, April 30, 2003 - Sonosite, Inc. (Nasdaq: SONO), the leader in point-of-care ultrasound, today released financial results for the first quarter ended March 31, 2003. In comparison to the first quarter of 2002, Sonosite reported a solid increase in revenues and increasing gross margins. Along with these financial results, in early April the Company launched its newest product, the TITAN high-resolution modular ultrasound system.For the quarter, Sonosite reported revenues of $17.2 million compared to $12.8 million for the first quarter of 2002, an increase of 33.6 percent. Sonosite reported a net loss of $2.6 million, or $0.18 per share, for the quarter. This compared to a net loss of $3.7 million, or $0.32 per share for the comparable quarter in the prior year.Gross margins increased for the ninth consecutive quarter to 62.9 percent, compared to 58.0 percent in the first quarter of 2002, and 60.3 percent in the fourth quarter of 2002. Gross margins rose as a result of a stronger mix from direct sales and advanced product configurations. As of March 31, 2003, cash, cash equivalents and investment securities totaled $64.9 million.… [Read more]
Upgrade Provides Complete Capabilities for Echo Studies;Addresses $460 Million International Shared Services Market… [Read more]
Conference Call Accessible Via Live WebcastBOTHELL, WA, July 16, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high-performance, hand-carried ultrasound, today announced that the Company will report its second quarter financial results on Thursday, July 29, 2004 at the close of market and hold a conference call at 1:30 pm PDT/4:30 pm EDT to discuss its second quarter performance, outlook for 2004 and current corporate developments. The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com. A replay of the audio webcast will be available beginning July 29, 2004, 4:30 pm (PDT) until August 13, 2004, 12:00 midnight (PDT) by dialing (719) 457 0820 or toll-free (888) 203 1112. The confirmation code (589270) is required to access the replay. The call will be also archived on Sonosite's website at http://ir.sonosite.com/. About Sonosite… [Read more]
Company Begins to Regain Momentum in JapanWorldwide Sales and Marketing Executive Team StrengthenedBOTHELL, WA, April 29, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced increased revenue and a reduced loss for the first quarter ended March 31, 2004 as compared with the first quarter of 2003. Worldwide revenue in the first quarter of 2004 grew 37% to $23.5 million compared to $17.2 million in the first quarter of 2003. The Company reported a net loss of $1.4 million or $0.10 per share for the quarter compared to a net loss of $2.6 million or $0.18 per share in the first quarter of 2003. As of March 31, 2004, cash, cash equivalents and investments grew to $64.1 million. The Company generated cash from operations of $2.8 million. … [Read more]
The Hand-carried Ultrasound Category Created By Sonosite Reaches Another Milestone In Just Over Three YearsBOTHELL, WA, February 3, 2003 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, announced today that the 10,000th Sonosite system has been delivered. This milestone has been met just 39 months after the company shipped its first 5.4 pound, all-digital, hand-carried ultrasound - the Sonosite 180 system.Sonosite's 10,000th system, the Sonosite 180PLUS, was delivered to Vanderbilt University Medical Center in Nashville, Tennessee for use in the Intensive Care Unit (ICU). Currently, Vanderbilt has five Sonosite hand-carried ultrasound systems throughout its health care facility, specifically in the interventional radiology, radiology, emergency medicine, and ICU departments.… [Read more]
Conference Call Accessible Via Live WebcastBOTHELL, WA, April 16, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high-performance, hand-carried ultrasound, today announced that the Company will report its first quarter financial results on Thursday, April 29, 2004 at the close of market and hold a conference call at 1:30 pm PDT/4:30 pm EDT to discuss its first quarter performance, outlook for 2004 and current corporate developments. The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com. A replay of the audio webcast will be available beginning April 29, 2004, 4:30 pm (PDT) until May 10, 2004, 12:00 midnight (PDT) by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 398334 is required to access the replay. The call will be also archived on Sonosite's website at http://ir.sonosite.com/. About Sonosite… [Read more]
A new dimension of diagnostic information: Strain analysis feature of Vevo® 2100 high-frequency ultrasound system enables highly sensitive and rapid measurement of global (whole heart) and regional (specific heart areas) cardiac function.
TORONTO, Canada - April 14, 2011 - VisualSonics Inc., a leader in real time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of Sonosite Inc., announced today that its VevoStrain™ technology has been featured on the cover of the April 15, 2011 issue of Circulation Research, Journal of the American Heart Association.… [Read more]
First-ever, All-digital Three-pound Ultrasound Tools Win The "Best of What's New" Award and Continue To Drive The "Visual Medicine" Trend
BOTHELL, WA, November 8, 2002 - Popular Science today recognized iLook, the world's smallest ultrasound series, as one of its top 10 medical technology advances for 2002 in its "Best of What's New" December 2002 issue. iLook is the world's first-ever, all-digital three-pound ultrasound tool and was recently launched by Sonosite, the creator and leader of the hand-carried ultrasound market.… [Read more]
Company Achieves Full Year Profitability Prior to Tax Benefit International Sales Up 52% and U.S. Sales Up 24% in the Fourth Quarter Conference Call Today at 1:30 pm PST/4:30 pm EST BOTHELL, WA, February 15, 2005 €“ Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today reported record financial results for the quarter and year ended December 31, 2004. Worldwide revenue in the fourth quarter of 2004 grew 36% to $37.1 million compared with $27.3 million in the fourth quarter of 2003. For the full year of 2004, the Company's total revenue grew 37% to $115.8 million compared with $84.8 million in the prior year. Year-over-year, changes in foreign currency rates increased the revenue growth rate by three percentage points for the fourth quarter and for the year.
In the fourth quarter of 2004, Sonosite achieved pre-tax income of approximately $3.5 million. In the fourth quarter of 2004, the Company recorded a one-time, non-cash tax benefit resulting from the reversal of the valuation allowance for US deferred taxes. Including the total tax benefit of $19.5 million, or $1.21 per diluted share, Sonosite reported net income in the fourth quarter of $23.0 million, or $1.42 per diluted share, compared with net income of approximately $2.2 million, or $0.15 per diluted share, in the fourth quarter of 2003.… [Read more]
Upgrade includes new transducers for pediatric cardiology and CW Doppler
DALLAS - November 13, 2005 - Sonosite, Inc. (NASDAQ: SONO), the world leader in hand-carried ultrasound, announced today the addition of new cardiology transducers and other imaging enhancements for its recently introduced, third generation product, the MicroMaxx' system. Existing MicroMaxx systems are compatible with the new capabilities. The company made the announcement at the 2005 American Heart Association (AHA) Scientific Sessions in Dallas. The MicroMaxx system, the size of a notebook and weighing less than eight pounds, delivers image resolution and performance comparable to costly, conventional cart-based ultrasound systems weighing over 200 pounds.… [Read more]
Palo Alto, Calif. - November 10, 2005 - Palo Alto, Calif. - November 10, 2005 - Frost & Sullivan selected Sonosite, Inc. as the recipient of the 2005 Medical Imaging Fastest Growing Company of the Year Award for its success in the U.S. medical imaging markets in 2004. Sonosite (Nasdaq:SONO) has received this Award for generating the highest percentage revenue growth while operating at a profit in the imaging market with more than 35 competing public companies. Each year Frost & Sullivan presents this Award to a company that has exhibited the highest percentage revenue growth in the market while maintaining profitability.
The Award signifies the company's commitment to developing and marketing technologically advanced products in the market being studied. Additionally, the Award highlights the key attributes of the company that were instrumental to its success. In 2004, Sonosite increased its revenue by 36.6 percent and is recognized in the financial community as one of the fastest growing technology companies in the United States with high sustained revenue growth over the five-year period from 2000 to 2004.… [Read more]
BOTHELL, WA - October 5, 2005 - Sonosite, Inc. (NASDAQ: SONO), the world leader in hand-carried ultrasound, has been named to Deloitte's prestigious Technology Fast 50 Program for Washington State, a ranking of the 50 fastest growing technology companies in the area by Deloitte & Touche LLP, one of the nation's leading professional services organizations. Rankings are based on the percentage revenue growth during a five-year span from 2000-2004. \
\"Since its inception in 1998, Sonosite has been the leader in designing, manufacturing and marketing hand-carried ultrasound systems for medical specialists across the clinical spectrum," said Kevin M.Goodwin, Sonosite President and CEO. "Our portfolio of hand-carried ultrasound systems provides medical professionals with the high-quality image they need to deliver rapid and appropriate care wherever the patient may be.
"Our newest product, the MicroMaxx system, represents the crossover point between hand-carried and cart based ultrasound systems. Its unique microchip technology, small footprint, high image quality and ruggedness together represent the spirit of creativity and innovation at Sonosite that I believe has driven our growth and earned the company its place on the Deloitte Fast 50."… [Read more]
Northwest Medical Device & Biotechnology Forum and UBS Global Life Sciences Conference BOTHELL, WA - September 14, 2005 - Sonosite, Inc. (NASDAQ: SONO), the world leader in hand-carried ultrasound, today announced that Mike Schuh, Chief Financial Officer, and Anne Bugge, Vice President of Corporate Affairs, will present at the Northwest Medical Device & Biotechnology Investor Forum at 10:00 a.m.
(ET) on Tuesday, September 20, 2005 at the Harvard Club of New York City. The forum is hosted by Delafield Hambrecht and WBBA. Sonosite also announced that Kevin M. Goodwin, President and CEO, will present at the 2005 UBS Global Life Sciences Conference at 12:30 p.m. (ET) on Wednesday, September 28 at the Grand Hyatt Hotel in New York City. Investors can access an audio-webcast of Mr. Goodwin's presentation on Sonosite's website. The webcast will be available beginning September 28, 2005, until 3:30 p.m. (ET) October 29, 2005.
About Sonosite
Headquartered near Seattle, Washington, Sonosite (www.sonosite.com) is represented by seven subsidiaries and a global distribution network in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 450 people worldwide.… [Read more]
Presentation to be webcast BOTHELL, WA - November 2, 2005 - Sonosite, Inc. (NASDAQ: SONO), the world leader in hand-carried ultrasound, today announced that Kevin M. Goodwin, President and CEO, will present at the 2005 RBC Dain Rauscher Northwest Investor Conference.
The conference will be held in Seattle at the Bell Harbor International Conference Center on Wednesday, November 9, 2005. Mr. Goodwin will present at 9:55 a.m. Investors can access an audio-webcast of Mr. Goodwin's presentation on Sonosite's website http://www.sonosite.com/webcast.html. The webcast will be available beginning November 9, 2005, until 3:30 p.m. (ET) December 10, 2005.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The company, headquartered near Seattle, Washington, is represented by eight subsidiaries and a global distribution network in over 75 countries. Approximately half of the company's revenues are generated from international markets. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs 470 people worldwide. … [Read more]
Ultrasound study to assess Carotid Intima Media Thickness in an office setting 525 patients to be enrolled at seven medical centers DALLAS - November 13, 2005 - Sonosite, Inc. (NASDAQ: SONO), the world leader in hand-carried ultrasound, announced today at the 2005 American Heart Association (AHA) Scientific Sessions that it is initiating a multi-center study to determine whether the addition of an ultrasound examination evaluating carotid artery wall thickness (CIMT), performed in the office setting, will provide a more effective tool for risk assessment and prevention of cardiovascular disease than current clinical methods alone.
Over 20 years of clinical research has shown that the thickness (T) of the two innermost layers of the carotid artery wall, the intima (I) and media (M), begins to increase before plaque is evident within the vessel. This increased wall thickness is associated with an increased risk of cardiovascular disease, the leading cause of mortality and disability in the United States today.
"IMT addresses the need to identify those patients who are asymptomatic or have limited risk factors, such as moderately elevated cholesterol levels, who may be at greater than apparent risk for a cardiovascular event," explains James H. Stein, MD, Associate Professor, University of Wisconsin Medical School. Dr. Stein is the Director of the University of Wisconsin Atherosclerosis Imaging Research Program and principal investigator of the study.… [Read more]
Accomplished Ultrasound Executive Brings 30 years of Industry Experience Bothell, WA - November 17, 2005, Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced the appointment of Dieter Schwartmann as Vice President of Europe and Acting Manager of Sonosite GmbH, the company's wholly-owned German subsidiary, effective December 1, 2005. Mr. Schwartmann brings 30 years of experience in the medical ultrasound and technology industry including serving as Vice President of Europe for ATL Ultrasound, Inc., now part of Philips Medical Systems. Under his leadership, sales for ATL Europe doubled in the period between 1995-2000.
From April of 2001 until May of 2004, Mr. Schwartmann was Vice President of the ultrasound business line of Philips Medical Systems with responsibility for Europe, the Middle East and Africa. He also served as a member of the Steering Committee overseeing the integration of Philips Medical Systems' acquisition of ATL Ultrasound and Agilent Technologies Healthcare Solutions Group Imaging Systems. Mr. Schwartmann joined ATL Ultrasound in 1990 as a Country Manager responsible for Germany, Eastern Europe and Russia. Most recently, Mr. Schwartmann was Vice President and board member of Aloka Holding Europe AG, a leading Japanese ultrasound manufacturer and distributor.… [Read more]